RCA
JNJ icon

Resonant Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Resonant Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.86M Sell
19,135
-294
-2% -$68.5K 0.23% 75
2026
Q1 		$4.75M Sell
19,429
-13,483
-41% -$3.14M 0.25% 67
2025
Q4 		$6.81M Buy
32,912
+1,265
+4% +$250K 0.37% 51
2025
Q3 		$5.87M Buy
31,647
+1,686
+6% +$289K 0.34% 56
2025
Q2 		$4.58M Buy
29,961
+1,308
+5% +$201K 0.29% 67
2025
Q1 		$4.75M Buy
28,653
+2,366
+9% +$370K 0.33% 59
2024
Q4 		$3.8M Buy
26,287
+356
+1% +$55.2K 0.28% 74
2024
Q3 		$4.2M Buy
25,931
+728
+3% +$116K 0.31% 67
2024
Q2 		$3.68M Sell
25,203
-1,115
-4% -$166K 0.3% 72
2024
Q1 		$4.16M Buy
26,318
+1,319
+5% +$210K 0.36% 60
2023
Q4 		$3.92M Sell
24,999
-1,789
-7% -$274K 0.38% 56
2023
Q3 		$4.17M Buy
26,788
+2,090
+8% +$345K 0.44% 48
2023
Q2 		$4.09M Buy
24,698
+2,134
+9% +$344K 0.44% 53
2023
Q1 		$3.5M Sell
22,564
-1,805
-7% -$291K 0.4% 60
2022
Q4 		$4.3M Buy
24,369
+1,171
+5% +$202K 0.54% 48
2022
Q3 		$3.79M Buy
23,198
+532
+2% +$90K 0.58% 47
2022
Q2 		$4.02M Buy
22,666
+177
+0.8% +$31.5K 0.63% 47
2022
Q1 		$4.01M Buy
22,489
+1,590
+8% +$271K 0.59% 40
2021
Q4 		$3.58M Buy
20,899
+3,251
+18% +$532K 0.54% 37
2021
Q3 		$2.85M Buy
17,648
+1,931
+12% +$329K 0.5% 42
2021
Q2 		$2.59M Buy
15,717
+339
+2% +$56.1K 0.5% 42
2021
Q1 		$2.53M Buy
15,378
+1,242
+9% +$201K 0.52% 36
2020
Q4 		$2.23M Buy
14,136
+626
+5% +$92.4K 0.53% 37
2020
Q3 		$2.01M Sell
13,510
-449
-3% -$66.4K 0.57% 34
2020
Q2 		$1.96M Sell
13,959
-4,210
-23% -$614K 0.57% 33
2020
Q1 		$2.38M Buy
18,169
+1,024
+6% +$145K 0.87% 24
2019
Q4 		$2.5M Buy
+17,145
New +$2.33M 0.79% 31

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Resonant Capital Advisors's JNJ Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $68.5K and leaving 19,135 shares worth $4.86M. The position accounts for 0.23% of the portfolio, ranked #75.

Resonant Capital Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.81M in Q4 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Resonant Capital Advisors held 19,135 shares of Johnson & Johnson worth $4.86M as of Q2 2026.
  • Resonant Capital Advisors sold 294 Johnson & Johnson shares in Q2 2026, an estimated $68.5K.
  • Johnson & Johnson made up 0.23% of Resonant Capital Advisors's portfolio in Q2 2026, its #75 holding.
  • Resonant Capital Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Resonant Capital Advisors's Johnson & Johnson position peaked at $6.81M in Q4 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.